Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jan 9:8:331.
doi: 10.3389/fnagi.2016.00331. eCollection 2016.

Commentary: Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies

Yassar Alamri  1 , Michael MacAskill  1 , Tim Anderson  1
Affiliations
Comment

Commentary: Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies

Yassar Alamri et al. Front Aging Neurosci. .
No abstract available

Keywords: Parkinson disease; cohort studies; dementia; harmonization; markers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Increasing numbers of PD biomarker-related articles, as indexed by MEDLINE® as of January 2016, are appearing in the literature.
See this image and copyright information in PMC

Comment on

References

    1. Abbott R. D., Ross G. W., Petrovitch H., Masaki K. H., Launer L. J., Nelson J. S., et al. (2016). Midlife milk consumption and substantia nigra neuron density at death. Neurology 86, 512–519. 10.1212/WNL.0000000000002254 - DOI - PMC - PubMed
    1. Azuaje F. (2011). Bioinformatics and Biomarker Discovery: ‘Omic’ Data Analysis for Personalized Medicine. West Sussex: John Wiley and Sons.
    1. Berg D., Lang A. E., Postuma R. B., Maetzler W., Deuschl G., Gasser T., et al. (2013). Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. Lancet Neurol. 12, 514–524. 10.1016/S1474-4422(13)70047-4 - DOI - PubMed
    1. Biomarkers Definitions Working Group (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 69, 89–95. 10.1067/mcp.2001.113989 - DOI - PubMed
    1. Dunckley T., Coon K. D., Stephan D. A. (2005). Discovery and development of biomarkers of neurological disease. Drug Discov. Today 10, 326–334. 10.1016/S1359-6446(04)03353-7 - DOI - PubMed

LinkOut - more resources